Original Article
Perioperative Beta-Blocker Therapy and Mortality after Major Noncardiac Surgery
N Engl J Med 2005; 353:349-361July 28, 2005
- Abstract
Background
Despite limited evidence from randomized trials, perioperative treatment with beta-blockers is now widely advocated. We assessed the use of perioperative beta-blockers and their association with in-hospital mortality in routine clinical practice.
Methods
We conducted a retrospective cohort study of patients 18 years of age or older who underwent major noncardiac surgery in 2000 and 2001 at 329 hospitals throughout the United States. We used propensity-score matching to adjust for differences between patients who received perioperative beta-blockers and those who did not receive such therapy and compared in-hospital mortality using multivariable logistic modeling.
Results
Of 782,969 patients, 663,635 (85 percent) had no recorded contraindications to beta-blockers, 122,338 of whom (18 percent) received such treatment during the first two hospital days, including 14 percent of patients with a Revised Cardiac Risk Index (RCRI) score of 0 and 44 percent with a score of 4 or higher. The relationship between perioperative beta-blocker treatment and the risk of death varied directly with cardiac risk; among the 580,665 patients with an RCRI score of 0 or 1, treatment was associated with no benefit and possible harm, whereas among the patients with an RCRI score of 2, 3, or 4 or more, the adjusted odds ratios for death in the hospital were 0.88 (95 percent confidence interval, 0.80 to 0.98), 0.71 (95 percent confidence interval, 0.63 to 0.80), and 0.58 (95 percent confidence interval, 0.50 to 0.67), respectively.
Conclusions
Perioperative beta-blocker therapy is associated with a reduced risk of in-hospital death among high-risk, but not low-risk, patients undergoing major noncardiac surgery. Patient safety may be enhanced by increasing the use of beta-blockers in high-risk patients.
Media in This Article
Figure 1
Adjusted Odds Ratio for In-Hospital Death Associated with Perioperative Beta-Blocker Therapy among Patients Undergoing Major Noncardiac Surgery, According to the RCRI Score and the Presence of Other Risk Factors in the Propensity-Matched Cohort and the Entire Study Cohort.Table 1
Characteristics of Patients Undergoing Major Noncardiac Surgery without Known Contraindications to Beta-Blockers, According to Whether They Received Beta-Blockers Perioperatively.Article Activity
- Article
More than 20 million operations are performed annually at hospitals throughout the United States,1 and although advances in operative and anesthetic techniques have reduced the risks associated with many procedures, some 1 in 10 patients can be expected to have a complication within 30 days after undergoing major surgery.2 Although they occur infrequently, postoperative cardiovascular complications are associated with a substantial risk of other complications and death,3,4 and preventing such complications is often the rationale for preoperative medical consultation.
Although the problem of postoperative myocardial infarction has been recognized for over 50 years,5 few prevention measures have proven effective. Conventional strategies have relied on prediction instruments to identify patients at heightened cardiac risk,6-9 noninvasive testing, cardiac catheterization followed by revascularization in selected patients, and careful perioperative monitoring. In the past decade, two influential randomized trials found that treatment with beta-blockers can decrease the incidence of myocardial infarction and death after noncardiac surgery.10,11 Because they appear efficacious, are inexpensive, and have few risks, beta-blockers are now widely advocated.12-16 In Making Health Care Safer, the Agency for Healthcare Research and Quality identified the perioperative use of beta-blockers among intermediate- and high-risk patients as one of the nation's “clear opportunities for safety improvement.”17 The National Quality Forum subsequently placed the use of beta-blockers among high-risk surgical patients on its list of 30 Safe Practices for Better Healthcare.18 Yet, two recent randomized trials19-21 reported no benefit from perioperative beta-blocker therapy and raised questions about the generalizability of earlier studies. While awaiting the results of large randomized trials,22 we evaluated the use and effectiveness of perioperative beta-blocker therapy in routine clinical practice.
Methods
Setting and Subjects
We conducted a retrospective cohort study using data from 329 hospitals that participate in Premier's Perspective, a database developed for measuring quality and use of health care. Participating hospitals represent all regions of the United States, are predominantly small-to-mid-size nonteaching facilities, and serve a largely urban patient population. In addition to the information available in the standard hospital-discharge file, the Perspective database contains a date-stamped log of all billed items, including medications and laboratory, diagnostic, and therapeutic services, for each patient.
Patients were included in our database if they were 18 years of age or older and had undergone major noncardiac surgery between January 1, 2000, and December 31, 2001. Surgical procedures were categorized with the use of APR-DRG software (version 15.0, 3M) and, on the basis of prior studies, were considered major if the median length of stay for patients in a given diagnosis-related group exceeded two days.9 Patients undergoing obstetrical procedures were excluded. Permission to conduct the study was granted by the institutional review board at Baystate Medical Center, where the study was conducted, and the need for written informed consent was waived.
Data Elements
For each patient, we noted the type of surgery, whether the admission was elective or emergency, and the hospital at which the operation took place. In addition to age, sex, and race or ethnic group, we recorded the presence or absence of known ischemic heart disease, congestive heart failure, cerebrovascular disease, hypertension, renal insufficiency, diabetes, and hyperlipidemia. The presence or absence of coexisting conditions was assessed with the use of the secondary diagnoses of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Furthermore, we considered a patient to have diabetes if there was a secondary diagnosis of diabetes mellitus or if the patient received treatment with an oral hypoglycemic agent during the hospitalization. In a secondary analysis, we expanded our definition of diabetes to include patients who were treated with insulin whether or not they received oral hypoglycemic agents or had a documented diagnosis of diabetes.
Perioperative administration of angiotensin-converting–enzyme inhibitors, angiotensin-receptor blockers, calcium-channel blockers, antiplatelet agents, lipid-lowering medications, loop diuretics, thiazide diuretics, antiarrhythmic agents, and dopamine or dobutamine was assessed with the use of pharmacy records. Information on prophylactic antibiotic administration and the use of pharmacologic and mechanical measures for the prevention of venous thromboembolism was gathered similarly. Data on in-hospital mortality, length of stay, and costs were obtained from the Perspective discharge file. In addition to information related to the admission, we noted each hospital's size, teaching status, and geographic location and whether it was urban or rural.
Adapting a classification scheme developed by Lee and colleagues, we calculated a Revised Cardiac Risk Index (RCRI) score for each patient, assigning one point for each of the following risk factors: high-risk surgery, ischemic heart disease, cerebrovascular disease, renal insufficiency, and diabetes mellitus.9 The category of high-risk surgery included all intrathoracic, intraperitoneal, and suprainguinal vascular procedures. Patients were excluded if they had received a secondary diagnosis that could be considered a contraindication to beta-blocker therapy; these included bradycardia, heart block, heart failure, hypotension, chronic obstructive pulmonary disease, and asthma.
Use of Beta-Blockers
We identified whether a beta-blocker had been administered either orally or intravenously at any time during the hospitalization, and if so, the date the medication was first administered. Because we lacked information about the date of the principal procedure as well as the goals of the ordering physicians, we considered a patient to have received beta-blocker therapy for prophylaxis, whether intentionally or not, if the first record of treatment occurred on the first or second hospital day. Patients who had treatment initiated on the third hospital day or later were grouped with those who did not receive a beta-blocker during the hospitalization, since this former group may have had therapy prescribed for the treatment of complications rather than for their prevention.
Statistical Analysis
Summary statistics were constructed with the use of frequencies and proportions for categorical data and means, medians, and interquartile ranges for continuous variables. We compared the characteristics of patients who received perioperative beta-blocker therapy during the first two hospital days with those who did not receive beta-blockers during the first two days. Chi-square and z tests were used to assess the relationship between treatment with beta-blockers and the risk of death in the hospital and any potential confounders.
We created a nonparsimonious logistic-regression model to derive a propensity score for early treatment with beta-blockers that included all patient and hospital characteristics as well as selected interaction terms. Each patient was assigned a propensity score that reflected the probability that they would receive early treatment. Using a Greedy 5-to-1 digit-matching algorithm,23 we matched each patient who received perioperative beta-blocker therapy with up to two patients who did not receive this therapy, starting with all five-digit propensity-score matches before moving to those with four or fewer matches, in an iterative process. These matching techniques were used to reduce bias introduced by incomplete or inexact matching.
The matched cohort was evaluated for differences between treatment groups in each of the potential confounding factors, and conditional logistic regression was used to assess the effect of beta-blockers on the risk of death in the hospital, after adjustment for any residual differences (given a P value of less than 0.01). Using both the matched and entire study cohorts, we examined the association between beta-blocker therapy and the risk of death in the hospital among patients on the basis of the RCRI score. In addition, in the entire study cohort we evaluated models for selected subpopulations, including patients with hypertension and an RCRI score of 0 and patients with an RCRI score of 1 and each of the individual RCRI factors. Interactions between beta-blocker treatment and unbalanced covariates were also evaluated for each model and retained if the resulting P value was less than 0.05. The Hosmer–Lemeshow goodness-of-fit test and the area under the curve were used to assess the fit of the model. All analyses were carried out with the use of SAS software (version 9.1).
Results
A total of 782,969 patients 18 years of age or older underwent major noncardiac surgery during the study period. Among this group, 119,334 (15 percent) had one or more documented potential contraindications to beta-blockade. Thus, 663,635 patients appeared to be eligible for perioperative treatment with beta-blockers. The median age was 62 years; slightly more than half were women, and two thirds were white (Table 1Table 1
Characteristics of Patients Undergoing Major Noncardiac Surgery without Known Contraindications to Beta-Blockers, According to Whether They Received Beta-Blockers Perioperatively.). Hypertension, diabetes, and ischemic heart disease were the most common coexisting conditions. Fifty percent had an RCRI score of 0, and 38 percent had an RCRI score of 1.In the secondary analysis, using the expanded definition of diabetes, we identified an additional 4 percent of the population as having this diagnosis; the additional patients classified as having diabetes shifted RCRI scores upward slightly. Orthopedic and abdominal operations accounted for 70 percent of procedures, 30 percent of the procedures were categorized as high risk, and just over half the admissions were elective. The median length of stay was five days. Overall, 13,454 eligible patients (2.0 percent) died during the hospitalization: 2839 of the 122,338 patients who received early treatment with beta-blockers (2.3 percent) and 10,615 of the 541,297 patients who did not receive beta-blockers or received them after the second hospital day (2.0 percent, P<0.001).
The majority of participating hospitals were in the South. Seventy-five percent had a capacity of 400 beds or less, 90 percent were nonteaching facilities, and 68 percent were in urban areas (Table 2Table 2
Characteristics of the 329 Hospitals.).Use of Beta-Blockers among Patients Undergoing Major Noncardiac Surgery
Of the 663,635 eligible patients, 122,338 (18 percent) received a beta-blocker on the first or second day of the hospitalization. Women were less likely than men to receive beta-blockers, and Hispanics, Asians, and other racial or ethnic groups were treated less frequently than whites and blacks (Table 1). A history of ischemic heart disease, a higher RCRI score, and hypertension were the characteristics most strongly associated with beta-blocker treatment. Treatment rates ranged from 14 percent among patients with an RCRI score of 0 to 44 percent among those with a score of 4 or higher. Patients whose operations were scheduled electively had higher rates of beta-blocker use than those whose procedures were classified as urgent or emergency, and patients who underwent vascular surgery were more likely to receive beta-blockers than were those undergoing other types of procedures. Hospitals located in the Northeast that served urban populations, had a bed capacity of at least 200, and were designated teaching hospitals were more likely to deliver beta-blocker therapy than were other types of hospitals.
Beta-Blocker Therapy and In-Hospital Mortality
Sixteen patients were excluded from multivariable modeling owing to missing data. We successfully matched 119,632 patients (98 percent) who received a beta-blocker in the early perioperative period with at least 1 patient who did not receive a beta-blocker or received it after the second hospital day (79 percent with two matches and 19 percent with one match) on the basis of the propensity score. In this propensity-matched cohort (Table 3Table 3
Characteristics of the Patients Who Received Beta-Blockers Perioperatively and Those Who Did Not Receive Such Therapy in the Propensity-Matched Cohort.), 2790 of 119,632 patients treated with beta-blockers died, as compared with 5123 of 216,290 patients who did not receive such therapy or who received it after the second hospital day (2.3 percent vs. 2.4 percent; match-adjusted odds ratio, 0.99; 95 percent confidence interval, 0.95 to 1.04; P=0.68).The preoperative RCRI score significantly modified the association between beta-blocker treatment and the risk of death in the hospital. Among the subgroup of patients included in the propensity analysis, early beta-blocker treatment was associated with a reduced risk of death among patients with scores of 3 or higher (Figure 1Figure 1
Adjusted Odds Ratio for In-Hospital Death Associated with Perioperative Beta-Blocker Therapy among Patients Undergoing Major Noncardiac Surgery, According to the RCRI Score and the Presence of Other Risk Factors in the Propensity-Matched Cohort and the Entire Study Cohort.), with odds ratios ranging from 1.43 (95 percent confidence interval, 1.29 to 1.58) among patients in the lowest RCRI category to 0.57 (95 percent confidence interval, 0.42 to 0.76) among those with an RCRI score of 4 or higher.Similar results were observed in the entire study cohort, except that a significant benefit of treatment was also observed among patients with an RCRI score of 2 (Figure 1). In a subgroup analysis of patients who had an RCRI score of 0 and hypertension, the odds ratio of death in the hospital was 0.96 (95 percent confidence interval, 0.82 to 1.13) among those who received beta-blockers early, as compared with those who did not receive them. Furthermore, among patients with an RCRI score of 1, we found no reduction in the risk of death in the hospital related to beta-blocker use in any subpopulation. On the basis of these results, the number needed to treat to prevent a single death in the hospital was 33 among those at highest risk, whereas, in instances in which the risk was increased with beta-blocker use, the number needed to harm (i.e., the number of patients who would need to be treated for a single death in the hospital to occur) was 208 among the lowest-risk patients, who were least likely to receive treatment with beta-blockers (Table 4Table 4
Rates and Risks of In-Hospital Death and the Numbers Needed to Treat and to Harm among Patients in the Entire Study Cohort Who Did Not Receive Perioperative Beta-Blockade, According to the RCRI Score and the Presence of Individual Risk Factors.).In a secondary analysis, using the expanded definition of diabetes, we observed generally similar results; however, the benefits of beta-blocker therapy were attenuated and were no longer significant for patients with an RCRI score of 2 (results are provided in the Supplementary Appendix, available with the full text of this article at www.nejm.org).
Discussion
Although evidence from randomized trials remains limited, the treatment of surgical patients with beta-blockers has been championed by clinicians and policymakers for its potential to enhance patient safety. In this large observational study, the perioperative administration of beta-blockers was associated with clear and clinically significant reductions in mortality among the 2 percent of surgical patients at highest risk (those with an RCRI score of 3 or greater) and appeared to be beneficial in the 10 percent of patients with an RCRI score of 2, but was of no benefit — and was possibly harmful — among patients in the lowest risk categories (those with an RCRI score of 0 or 1). Our observation that only a minority of patients at highest risk received beta-blockers underscores the Agency for Healthcare Research and Quality's statement that perioperative use of beta-blockade represents a clear opportunity for safety improvement.17
Two randomized trials have shown that the use of beta-blockers decreases the risk of death among surgical patients. The Multicenter Study of Perioperative Ischemia Research Group10 randomly assigned 200 male veterans with known coronary artery disease or two or more coronary risk factors to receive atenolol or placebo before undergoing major noncardiac surgery and reported that within several months after discharge, treated patients had a significant survival advantage. Poldermans et al.11 randomly assigned 112 patients with abnormal stress echocardiograms to receive bisoprolol or placebo before and after vascular surgery and found a marked reduction in the risk of myocardial infarction and death during hospitalization and at 30 days postoperatively.
Two recently completed trials have, however, raised questions about the generalizability of the earlier studies. In the first, patients undergoing vascular surgery who were randomly assigned to receive metoprolol had rates of major cardiovascular complications or death from cardiac causes at 30 days that were similar to the rates among those who received placebo.19 In the second, 921 patients with diabetes who were randomly assigned to receive metoprolol or placebo20,21 had similar rates of a composite end point of death from any cause or major cardiovascular complications after a median follow-up of 18 months. It is unclear whether the lack of benefit in these recent trials can be explained by differences in treatment protocols or by lower-than-expected rates of events, which would have reduced the statistical power of the studies to detect a moderate effect of treatment.
By evaluating the effect of beta-blocker therapy in a diverse population undergoing a wide variety of surgical procedures at more than 300 hospitals throughout the United States, our results extend the findings from these earlier studies and provide support for the perioperative use of beta-blockers in high-risk patients, while we await the results of a large, ongoing, randomized trial.22 Yet the lack of benefit of this approach in moderate-risk patients and the potential harm of this approach in the lowest-risk groups suggest that careful patient selection remains necessary.
Our study has some limitations. First, treatment with beta-blockers was not based on random assignment, and results may be confounded by other variables. Although we used rigorous statistical methods to adjust for baseline differences between patients, including propensity-score matching and stratification, the retrospective nature of the study meant that our ability to control for differences was limited to variables for which data were available. Furthermore, because we relied on claims data, the ascertainment of coexisting conditions and potential contraindications to beta-blocker treatment was dependent on physicians' documentation and hospitals' coding practices. Although previous studies have validated the use of administrative data for these purposes,24,25 they also suggest that we may have underestimated the prevalence of some coexisting conditions. We noted that a substantially greater number of patients were classified as having diabetes when we added insulin use as a diagnostic criterion in the absence of an ICD-9-CM code for diabetes. Insofar as we underestimated the prevalence of coexisting conditions, our effect estimates among lower-risk patients may be overly optimistic, whereas the percentage of the population that might actually benefit from beta-blockers could be larger than the 2 to 12 percent we forecast.
An additional limitation was that our study was restricted to the period of hospitalization. We did not have access to information about the use of beta-blockers before admission or after discharge and were unable to report 30-day or 1-year mortality rates. Nevertheless, other trials of perioperative beta-blocker therapy have used protocols in which treatment was begun only hours before surgery and have generally relied on longer-term outcomes because they have been statistically underpowered to detect short-term differences.10,19-21 Furthermore, we presumed that patients who were treated with a beta-blocker on the first or second hospital day were given the drug for prophylaxis; however, it is likely that some of these patients were actually given beta-blockers for the treatment of postoperative ischemia or infarction. Such misclassification was more likely among the lowest-risk patients, who were least likely to receive prophylaxis. To the extent that we misclassified patients in this way, our results would underestimate the effectiveness of beta-blocker therapy or would incorrectly suggest that beta-blockers were harmful.
Without access to patients' charts, we could not determine the effect of beta-blocker treatment on heart rates before, during, or after surgery. Finally, because administrative data are not a reliable source of information about postoperative cardiovascular complications,26 we were unable to report the incidence of ischemia or infarction.
We found that perioperative administration of beta-blockers was associated with a reduced risk of death in the hospital among high-risk patients undergoing major noncardiac surgery. Thus, until the results of large randomized trials become available, ongoing national efforts to increase patient safety by increasing the perioperative use of beta-blockers among high-risk patients appear warranted.
Presented at the annual meeting of the Society of General Internal Medicine, Vancouver, B.C., Canada, May 1, 2003.
We are indebted to Andrew Auerbach, M.D., M.P.H., and Michael Rothberg, M.D., M.P.H., for their comments on an earlier version of the manuscript.
Source Information
From the Division of Healthcare Quality, Baystate Medical Center, Springfield, Mass. (P.K.L., P.P., E.M.B.); the Department of Medicine, Tufts University School of Medicine, Boston (P.K.L., E.M.B.); the School of Public Health and Health Sciences, University of Massachusetts at Amherst, Amherst (P.P., K.W., D.K.M.); and Premier Healthcare Informatics, Premier Inc., Charlotte, N.C. (B.G.)
Address reprint requests to Dr. Lindenauer at the Division of Healthcare Quality, Baystate Medical Center, 759 Chestnut St. P-5928, Springfield, MA 01199, or at Peter.Lindenauer@bhs.org.
- References
References
1
Hall MJ, Owings MF. 2000 National Hospital Discharge Survey. Advance data from vital and health statistics. No. 329. Hyattsville, Md.: National Center for Health Statistics, June 2002. (DHHS publication no. (PHS) 2002-1250 02-0428.)
2
Khuri SF ,Daley J ,Henderson W , et al. The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. Ann Surg 1998;228:491-507
CrossRef | Web of Science | Medline3
Nettleman MD ,Banitt L ,Barry W ,Awan I ,Gordon EEI . Predictors of survival and the role of gender in postoperative myocardial infarction. Am J Med 1997;103:357-362
CrossRef | Web of Science | Medline4
Lindenauer PK ,Fitzgerald J ,Hoople N ,Benjamin EM . The potential preventability of postoperative myocardial infarction: underuse of perioperative beta-adrenergic blockade. Arch Intern Med 2004;164:762-766
CrossRef | Web of Science | Medline5
Wroblewski F ,LaDue JS . Myocardial infarction as a post-operative complication of major surgery. JAMA 1952;150:1212-1216
Web of Science | Medline6
Goldman L ,Caldera DL ,Nussbaum SR , et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845-850
Full Text | Web of Science | Medline7
Detsky AS ,Abrams HB ,Forbath N ,Scott JG ,Hilliard JR . Cardiac assessment for patients undergoing noncardiac surgery: a multifactorial clinical risk index. Arch Intern Med 1986;146:2131-2134
CrossRef | Web of Science | Medline8
Eagle KA ,Coley CM ,Newell JB , et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989;110:859-856
Web of Science | Medline9
Lee TH ,Marcantonio ER ,Mangione CM , et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-1049
Web of Science | Medline10
Mangano DT ,Layug EL ,Wallace A ,Tateo I . Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996;335:1713-1720[Erratum, N Engl J Med 1997;336:1039.]
Full Text | Web of Science | Medline11
Poldermans D ,Boersma E ,Bax JJ , et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999;341:1789-1794
Full Text | Web of Science | Medline12
Auerbach AD ,Goldman L . Beta-blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA 2002;287:1435-1444
CrossRef | Web of Science | Medline13
Fleisher LA ,Eagle KA . Lowering cardiac risk in noncardiac surgery. N Engl J Med 2001;345:1677-1682
Full Text | Web of Science | Medline14
Cohn SL ,Goldman L . Preoperative risk evaluation and perioperative management of patients with coronary artery disease. Med Clin North Am 2003;87:111-136
CrossRef | Web of Science | Medline15
Selzman CH ,Miller SA ,Zimmerman MA ,Harken AH . The case for β-adrenergic blockade as prophylaxis against perioperative cardiovascular morbidity and mortality. Arch Surg 2001;136:286-290
CrossRef | Web of Science | Medline16
Grayburn PA ,Hillis LD . Cardiac events in patients undergoing noncardiac surgery: shifting the paradigm from noninvasive risk stratification to therapy. Ann Intern Med 2003;138:506-511
Web of Science | Medline17
Shojania KG, Duncan BW, McDonald KM, Wachter RM, eds. Making health care safer: a critical analysis of patient safety practices. Evidence report/technology assessment. No. 43. Rockville, Md.: Agency for Healthcare Research and Quality, July 2001. (AHRQ publication no. 01-E058.)
18
Safe practices for better healthcare: a consensus report. Washington, D.C.: National Quality Forum, 2003. (Publication no. NQFCR-05-03.)
19
Yang H ,Raymer K ,Butler R ,Parlow J ,Roberts R ,Tech M . Metoprolol after vascular surgery (MaVS). Can J Anaesth 2004;51:A7-A7 abstract.20
Juul AB. Randomized, blinded trial on perioperative metoprolol versus placebo for diabetic patients undergoing noncardiac surgery. Presented at Late-Breaking Clinical Trials I, American Heart Association Scientific Sessions 2004, New Orleans, November 7–10, 2004. abstract.
21
Juul AB ,Wetterslev J ,Kofoed-Enevoldsen A , et al. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. Am Heart J 2004;147:677-683
CrossRef | Web of Science | Medline22
Devereaux PJ ,Yusuf S ,Yang H ,Choi PT-L ,Guyatt GH . Are the recommendations to use perioperative β-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence? CMAJ 2004;171:245-247
CrossRef | Web of Science | Medline23
Parsons LS. Reducing bias in a propensity score matched-pair sample using Greedy matching techniques. In: Proceedings of the Twenty-Sixth Annual SAS Users Group International Conference, Long Beach, Calif., April 22–25, 2001. Cary, N.C.: SAS Institute, 2001.
24
Quan H ,Parsons GA ,Ghali WA . Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care 2002;40:675-685
CrossRef | Web of Science | Medline25
Elixhauser A ,Steiner C ,Harris DR ,Coffey RM . Comorbidity measures for use with administrative data. Med Care 1998;36:8-27
CrossRef | Web of Science | Medline26
Best WR ,Khuri SF ,Phelan M , et al. Identifying patient preoperative risk factors and postoperative adverse events in administrative databases: results from the Department of Veterans Affairs National Surgical Quality Improvement Program. J Am Coll Surg 2002;194:257-266
CrossRef | Web of Science | Medline
- Citing Articles (230)
Citing Articles
1
Sloane Berger-Chen, Thomas J. Herzog, Sharyn N. Lewin, William M. Burke, Alfred I. Neugut, Dawn L. Hershman, Jason D. Wright. (2012) Access to Conservative Surgical Therapy for Adolescents With Benign Ovarian Masses. Obstetrics & Gynecology 119:2, Part 1, 270-275
CrossRef2
Takeshi Omae, Yuichi Kanmura. (2012) Management of postoperative atrial fibrillation. Journal of Anesthesia
CrossRef3
S.-i. Yamashita, K. Tokuishi, K. Anami, T. Moroga, M. Miyawaki, M. Chujo, S. Yamamoto, K. Kawahara. (2012) Thoracoscopic segmentectomy for T1 classification of non-small cell lung cancer: a single center experience. European Journal of Cardio-Thoracic Surgery
CrossRef4
Brigid C. Flynn, George Silvay. (2012) Value of Specialized Preanesthetic Clinic for Cardiac and Major Vascular Surgery Patients. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 79:1, 13-24
CrossRef5
Eun-Ho Lee, Sung-Cheol Yun, Ji-Hyun Chin, Dae-Kee Choi, Hyo-Jung Son, Wook-Chong Kim, Seong-Soo Choi, Jun-Gol Song, Kyung-Don Hahm, Ji-Yeon Sim, In-Cheol Choi. (2012) Prognostic Implications of Preoperative E/e′ Ratio in Patients with Off-pump Coronary Artery Surgery. Anesthesiology1
CrossRef6
B. C. Flynn, W. J. Vernick, J. E. Ellis. (2011) -Blockade in the perioperative management of the patient with cardiac disease undergoing non-cardiac surgery. British Journal of Anaesthesia 107:suppl 1, i3-i15
CrossRef7
Michol Cooper, Martin A. Makary. (2011) A Comprehensive Unit-Based Safety Program (CUSP) in Surgery: Improving Quality Through Transparency. Surgical Clinics of North America
CrossRef8
Jason D. Wright, Dawn L. Hershman, Monjri Shah, William M. Burke, Xuming Sun, Alfred I. Neugut, Sharyn N. Lewin, Thomas J. Herzog. (2011) Quality of Perioperative Venous Thromboembolism Prophylaxis in Gynecologic Surgery. Obstetrics & Gynecology 118:5, 978-986
CrossRef9
M. Damm, A. Hübler, A.R. Heller. (2011) Kardioprotektion. Der Anaesthesist 60:11, 1065-1082
CrossRef10
Yasuaki Mizushima, Masato Ueno, Hiroaki Watanabe, Kazuo Ishikawa, Tetsuya Matsuoka. (2011) Discrepancy Between Heart Rate and Makers of Hypoperfusion Is a Predictor of Mortality in Trauma Patients. The Journal of Trauma: Injury, Infection, and Critical Care 71:4, 789-792
CrossRef11
E.J. Bakker, N.J. Ravensbergen, M.T. Voute, S.E. Hoeks, M. Chonchol, M. Klimek, D. Poldermans. (2011) A Randomised Study of Perioperative Esmolol Infusion for Haemodynamic Stability during Major Vascular Surgery; Rationale and Design of DECREASE-XIII. European Journal of Vascular and Endovascular Surgery 42:3, 317-323
CrossRef12
T. Nowak, E. Weisflog, H. Böhner, H. Wenk. (2011) Perioperative Medikation bei arteriellen Operationen. Gefässchirurgie 16:5, 324-329
CrossRef13
Jason D. Wright, Sharyn N. Lewin, Israel Deutsch, William M. Burke, Xuming Sun, Thomas J. Herzog. (2011) The influence of surgical volume on morbidity and mortality of radical hysterectomy for cervical cancer. American Journal of Obstetrics and Gynecology 205:3, 225.e1-225.e7
CrossRef14
Vin-Cent Wu, Tao-Min Huang, Chun-Fu Lai, Chih-Chung Shiao, Yu-Feng Lin, Tzong-Shinn Chu, Pei-Chen Wu, Chia-Ter Chao, Jann-Yuan Wang, Tze-Wah Kao, Guang-Huar Young, Pi-Ru Tsai, Hung-Bin Tsai, Chieh-Li Wang, Ming-Shou Wu, Wen-Chih Chiang, I-Jung Tsai, Fu-Chang Hu, Shuei-Liong Lin, Yung-Ming Chen, Tun-Jun Tsai, Wen-Je Ko, Kwan-Dun Wu. (2011) Acute-on-chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality. Kidney International
CrossRef15
A. Kumar, M. Auron, A. Aneja, F. Mohr, A. Jain, B. Shen. (2011) Inflammatory Bowel Disease: Perioperative Pharmacological Considerations. Mayo Clinic Proceedings 86:8, 748-757
CrossRef16
Matthias Bock, Christian J. Wiedermann, Johann Motsch, Gerhard Fritsch, Markus Paulmichl. (2011) Minimizing cardiac risk in perioperative practice – interdisciplinary pharmacological approaches. Wiener klinische Wochenschrift 123:13-14, 393-407
CrossRef17
Duminda N Wijeysundera. (2011) Preoperative consultations by anesthesiologists. Current Opinion in Anaesthesiology 24:3, 326-330
CrossRef18
Nijst Petra, Vercauteren Roeland, Vanderschueren Steven, Vandermeulen Erik. (2011) Perioperative beta-blocker therapy: How to see the forest for the trees?. European Journal of Internal Medicine 22:3, e20-e21
CrossRef19
Jason D. Wright, Sharyn N. Lewin, Monjri Shah, William M. Burke, Shing M. Lee, Xuming Sun, Thomas J. Herzog. (2011) Quality of Venous Thromboembolism Prophylaxis in Patients Undergoing Oncologic Surgery. Annals of Surgery 253:6, 1140-1146
CrossRef20
Masha Livhits, Clifford Y. Ko, Michael J. Leonardi, David S. Zingmond, Melinda Maggard Gibbons, Christian de Virgilio. (2011) Risk of Surgery Following Recent Myocardial Infarction. Annals of Surgery 253:5, 857-864
CrossRef21
Philip P. Goodney, Jens Eldrup-Jorgensen, Brian W. Nolan, Daniel J. Bertges, Donald S. Likosky, Jack L. Cronenwett. (2011) A regional quality improvement effort to increase beta blocker administration before vascular surgery. Journal of Vascular Surgery 53:5, 1316-1328.e1
CrossRef22
Ashraf A. Fayad, Homer Y. Yang, Terrence D. Ruddy, James M. Watters, George A. Wells. (2011) Perioperative myocardial ischemia and isolated systolic hypertension in non-cardiac surgery. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 58:5, 428-435
CrossRef23
Jason D. Wright, Sharyn N. Lewin, Israel Deutsch, William M. Burke, Xuming Sun, Thomas J. Herzog. (2011) Effect of Surgical Volume on Morbidity and Mortality of Abdominal Hysterectomy for Endometrial Cancer. Obstetrics & Gynecology 117:5, 1051-1059
CrossRef24
G. L. Ackland. (2011) Reply from the authors. British Journal of Anaesthesia 106:5, 751-751
CrossRef25
Denis Bouchard, Michel Carrier, Philippe Demers, Raymond Cartier, Michel Pellerin, Louis P. Perrault, Jean Lambert. (2011) Statin in Combination With β-Blocker Therapy Reduces Postoperative Stroke After Coronary Artery Bypass Graft Surgery. The Annals of Thoracic Surgery 91:3, 654-659
CrossRef26
Joshua J Augustine, Kenneth A Bodziak, Aparna Padiyar, James A Schulak, Donald E Hricik. 2011. Kidney and Pancreas Transplantation. , 129-170.
CrossRef27
Suzanne Flier, Wolfgang F Buhre, Wilton A van Klei. (2011) Cardioprotective effects of perioperative β-blockade in vascular surgery patients: fact or fiction?. Current Opinion in Anaesthesiology 24:1, 104-110
CrossRef28
Yu-Hsiang Chou, Tao-Min Huang, Vin-Cent Wu, Cheng-Yi Wang, Chih-Chung Shiao, Chun-Fu Lai, Hung-Bin Tsai, Chia-Ter Chao, Guang-Huar Young, Wei-Jei Wang, Tze-Wah Kao, Shuei-Liong Lin, Yin-Yi Han, Anne Chou, Tzu-Hsin Lin, Ya-Wen Yang, Yung-Ming Chen, Pi-Ru Tsai, Yu-Feng Lin, Jenq-Wen Huang, Wen-Chih Chiang, Nai-Kuan Chou, Wen-Je Ko, Kwan-Dun Wu, Tun-Jun Tsai, . (2011) Impact of timing of renal replacement therapy initiation on outcome of septic acute kidney injury. Critical Care 15:3, R134
CrossRef29
Steffen Christensen, Martin Johansen, Else Tønnesen, Anders Larsson, Lars Pedersen, Stanley Lemeshow, Henrik Sørensen. (2011) Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study. Critical Care 15:2, R87
CrossRef30
Chris Dudley, Paul Harden. (2011) Renal Association Clinical Practice Guideline on the Assessment of the Potential Kidney Transplant Recipient. Nephron Clinical Practice 118:s1, c209-c224
CrossRef31
Satoshi Suzuki, Hiroshi Morimatsu, Moritoki Egi, Kazuyoshi Shimizu, Takashi Matsusaki, Tetsufumi Sato, Hiroshi Katayama, Kiyoshi Morita. (2011) Nihon Shuchu Chiryo Igakukai zasshi 18:2, 215-220
CrossRef32
Brian H Cuthbertson, Marion K Campbell, Stephen A Stott, Andrew Elders, Rodolfo Hernandez, Dwayne Boyers, John Norrie, John Kinsella, Julie Brittenden, Jonathan Cook, Daniela Rae, Seonaidh C Cotton, David Alcorn, Jennifer Addison, Adrian Grant, Foccus Study group. (2011) A pragmatic multi-centre randomised controlled trial of fluid loading in high-risk surgical patients undergoing major elective surgery - the FOCCUS study. Critical Care 15:6, R296
CrossRef33
Radmilo Jankovic, Angelina Bogicevic, Biljana Stosic, Anica Pavlovic, Anita Petrovic, Dejan Markovic, Cedomir Vucetic. (2011) Preoperative preparation of geriatric patients. Acta chirurgica iugoslavica 58:2, 169-175
CrossRef34
Nicolas Allou, Pascal Augustin, Guillaume Dufour, Laura Tini, Hassan Ibrahim, Marie-Pierre Dilly, Philippe Montravers, Joshua Wallace, Sophie Provenchère, Ivan Philip. (2010) Preoperative Statin Treatment Is Associated With Reduced Postoperative Mortality After Isolated Cardiac Valve Surgery in High-Risk Patients. Journal of Cardiothoracic and Vascular Anesthesia 24:6, 921-926
CrossRef35
Lisa J. Rogo-Gupta, Sharyn N. Lewin, Jin Hee Kim, William M. Burke, Xuming Sun, Thomas J. Herzog, Jason D. Wright. (2010) The Effect of Surgeon Volume on Outcomes and Resource Use for Vaginal Hysterectomy. Obstetrics & Gynecology 116:6, 1341-1347
CrossRef36
A. Tung. (2010) Anaesthetic considerations with the metabolic syndrome. British Journal of Anaesthesia 105:Supplement 1, i24-i33
CrossRef37
G. L. Ackland, S. Harris, Y. Ziabari, M. Grocott, M. Mythen, . (2010) Revised cardiac risk index and postoperative morbidity after elective orthopaedic surgery: a prospective cohort study. British Journal of Anaesthesia 105:6, 744-752
CrossRef38
Andrew D. Auerbach, Judith Maselli, Jonathan Carter, Penelope S. Pekow, Peter K. Lindenauer. (2010) The Relationship between Case Volume, Care Quality, and Outcomes of Complex Cancer Surgery. Journal of the American College of Surgeons 211:5, 601-608
CrossRef39
Willem-Jan Flu, Jan-Peter van Kuijk, Michel Chonchol, Tamara A. Winkel, Hence J.M. Verhagen, Jeroen J. Bax, Don Poldermans. (2010) Timing of Pre-Operative Beta-Blocker Treatment in Vascular Surgery Patients. Journal of the American College of Cardiology 56:23, 1922-1929
CrossRef40
Andrew Friedrich, Tarek Helmy. (2010) Prevention of Perioperative Myocardial Infarction. International Anesthesiology Clinics 47:4, 13-36
CrossRef41
Kok-Yang Tan, Fumio Konishi, Lawrence Tan, Wui-Kin Chin, Hean-Yee Ong, Phyllis Tan. (2010) Optimizing the management of elderly colorectal surgery patients. Surgery Today 40:11, 999-1010
CrossRef42
Pierre Foëx, John W. Sear. (2010) Challenges of β-Blockade in Surgical Patients. Anesthesiology 113:4, 767-771
CrossRef43
Arthur W. Wallace, Selwyn Au, Brian A. Cason. (2010) Association of the Pattern of Use of Perioperative β-Blockade and Postoperative Mortality. Anesthesiology 113:4, 794-805
CrossRef44
Jay Menaker, Thomas M. Scalea. (2010) Geriatric care in the surgical intensive care unit. Critical Care Medicine 38, S452-S459
CrossRef45
Eric J. Ley, Cherisse Berry, James Mirocha, Ali Salim. (2010) Mortality is Reduced for Heart Rate 80 to 89 After Traumatic Brain Injury. Journal of Surgical Research 163:1, 142-145
CrossRef46
Daniel J. Bertges, Philip P. Goodney, Yuanyuan Zhao, Andres Schanzer, Brian W. Nolan, Donald S. Likosky, Jens Eldrup-Jorgensen, Jack L. Cronenwett. (2010) The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients. Journal of Vascular Surgery 52:3, 674-683.e3
CrossRef47
Craig J. Railton, Jacob Wolpin, Jenny Lam-McCulloch, Susan E. Belo. (2010) Renin-angiotensin blockade is associated with increased mortality after vascular surgery. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 57:8, 736-744
CrossRef48
Nicola Troisi, Walter Dorigo, Patrizia Lo Sapio, Giovanni Pratesi, Raffaele Pulli, Gian Franco Gensini, Carlo Pratesi. (2010) Preoperative Cardiac Assessment in Patients Undergoing Aortic Surgery: Analysis of Factors Affecting the Cardiac Outcomes. Annals of Vascular Surgery 24:6, 733-740
CrossRef49
Nicola Troisi, Walter Dorigo, Patrizia Lo Sapio, Giovanni Pratesi, Raffaele Pulli, Gian Franco Gensini, Carlo Pratesi. (2010) Bilan cardiaque préopératoire des patients pour chirurgie aortique : analyse des facteurs influençant les suites cardiaques. Annales de Chirurgie Vasculaire 24:6, 800-807
CrossRef50
Justin Woods, Andrew Rhodes. 2010. Care of the High Risk Patient Undergoing Surgery. , 154-166.
CrossRef51
A. Cassar, D. Poldermans, C. S. Rihal, B. J. Gersh. (2010) The management of combined coronary artery disease and peripheral vascular disease. European Heart Journal 31:13, 1565-1572
CrossRef52
Terence Lin, Nahidh W. Hasaniya, Susan Krider, Anees Razzouk, Nan Wang, Jun R. Chiong. (2010) Mortality Reduction With β-Blockers in Ischemic Cardiomyopathy Patients Undergoing Coronary Artery Bypass Grafting. Congestive Heart Failure 16:4, 170-174
CrossRef53
B. Preckel, M. Poels, F. Wappler, W. Schlack, W. Buhre. (2010) Perioperative β-Rezeptoren-Blockade. Der Anaesthesist 59:7, 643-651
CrossRef54
Jason D. Wright, Thomas J. Herzog, Monjri Shah, Clarissa Bonanno, Sharyn N. Lewin, Kirsten Cleary, Lynn L. Simpson, Sreedhar Gaddipati, Xuming Sun, Mary E. DʼAlton, Patricia Devine. (2010) Regionalization of Care for Obstetric Hemorrhage and Its Effect on Maternal Mortality. Obstetrics & Gynecology 115:6, 1194-1200
CrossRef55
Jun Wang, Jing Li, Xiao Sheng, Hui Zhao, Xiao-Ding Cao, Yan-Qing Wang, Gen-Cheng Wu. (2010) β-adrenoceptor mediated surgery-induced production of pro-inflammatory cytokines in rat microglia cells. Journal of Neuroimmunology 223:1-2, 77-83
CrossRef56
Lee A. Fleisher. (2010) Improving Perioperative Outcomes: My Journey into Risk, Patient Preferences, Guidelines, and Performance Measures. Anesthesiology 112:4, 794-801
CrossRef57
Andrew B. Leibowitz. (2010) Can Meta-analysis of the Current Literature Help Determine if Perioperative β-Blockers Improve Outcome of High-Risk Patients Undergoing Noncardiac Surgery?. Journal of Cardiothoracic and Vascular Anesthesia 24:2, 217-218
CrossRef58
Vin-Cent Wu, Chih-Hsien Wang, Wei-Jie Wang, Yu-Feng Lin, Fu-Chang Hu, Yung-Wei Chen, Yih-Sharng Chen, Ming-Shiou Wu, Yen-Hung Lin, Chin-Chi Kuo, Tao-Min Huang, Yung-Ming Chen, Pi-Ru Tsai, Wen-Je Ko, Kwan-Dun Wu. (2010) Sustained low-efficiency dialysis versus continuous veno-venous hemofiltration for postsurgical acute renal failure. The American Journal of Surgery 199:4, 466-476
CrossRef59
J. A. Rassen, M. A. Mittleman, R. J. Glynn, M. Alan Brookhart, S. Schneeweiss. (2010) Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention. European Heart Journal 31:5, 561-572
CrossRef60
J. W. Sear, P. Foex. (2010) Recommendations on perioperative -blockers: differing guidelines: so what should the clinician do?. British Journal of Anaesthesia 104:3, 273-275
CrossRef61
Benjamin S. Brooke. (2010) Perioperative β-blockers for vascular surgery patients. Journal of Vascular Surgery 51:2, 515-519
CrossRef62
Don Poldermans, Jeroen J Bax, Eric Boersma, Stefan De Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, Jose Lopez-Sendon, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav FM Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen. (2010) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. European Journal of Anaesthesiology 27:2, 92-137
CrossRef63
Kartikya Ahuja, Mitchell H. Charap. (2010) Management of perioperative hypertensive urgencies with parenteral medications. Journal of Hospital Medicine 5:2, E11-E16
CrossRef64
G. Illuminati, J.-B. Ricco, C. Greco, E. Mangieri, F. Calio', G. Ceccanei, M.A. Pacilè, M. Schiariti, G. Tanzilli, F. Barillà, V. Paravati, G. Mazzesi, F. Miraldi, L. Tritapepe. (2010) Systematic Preoperative Coronary Angiography and Stenting Improves Postoperative Results of Carotid Endarterectomy in Patients with Asymptomatic Coronary Artery Disease: A Randomised Controlled Trial. European Journal of Vascular and Endovascular Surgery 39:2, 139-145
CrossRef65
Felix van Lier, Olaf Schouten, Sanne E. Hoeks, Louis van de Ven, Robert Jan Stolker, Jeroen J. Bax, Don Poldermans. (2010) Impact of Prophylactic β-Blocker Therapy to Prevent Stroke After Noncardiac Surgery. The American Journal of Cardiology 105:1, 43-47
CrossRef66
Vanitha Sivanaser, Pirjo Manninen. (2010) Preoperative Assessment of Adult Patients for Intracranial Surgery. Anesthesiology Research and Practice 2010, 1-11
CrossRef67
Shinji TAKAHASHI. (2010) How to Manage Sudden Tachyarrhythmia during the Perioperative Period-How to Use Beta-Blockers in the Management of Tachyarrhythmia-. THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA 30:5, 779-784
CrossRef68
Takeshi OMAE. (2010) Control of Postoperative Atrial Fibrillation. THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA 30:5, 771-778
CrossRef69
Brechtje A. Grotenhuis, Bas P.L. Wijnhoven, Frank Grüne, Jasper van Bommel, Hugo W. Tilanus, J. Jan B. van Lanschot. (2010) Preoperative risk assessment and prevention of complications in patients with esophageal cancer. Journal of Surgical Oncologyn/a-n/a
CrossRef70
Richard B. Weiskopf. (2010) Perioperative Use of β-Adrenergic Antagonists and Anemia. Anesthesiology 112:1, 12-15
CrossRef71
W Scott Beattie, Duminda N. Wijeysundera, Keyvan Karkouti, Stuart McCluskey, Gordon Tait, Nicholas Mitsakakis, Gregory M. T. Hare. (2010) Acute Surgical Anemia Influences the Cardioprotective Effects of β-Blockade. Anesthesiology 112:1, 25-33
CrossRef72
Giuseppe Crescenzi, Giovanni Landoni, Fabrizio Monaco, Elena Bignami, Monica De Luca, Giovanna Frau, Concetta Rosica, Alberto Zangrillo. (2009) Epidural Anesthesia in Elderly Patients Undergoing Coronary Artery Bypass Graft Surgery. Journal of Cardiothoracic and Vascular Anesthesia 23:6, 807-812
CrossRef73
Sachin Kheterpal, Derek T. Woodrum, Kevin K. Tremper. (2009) Too Much of a Good Thing Is Wonderful. Anesthesiology 111:6, 1183-1184
CrossRef74
José López-Sendón, Eduardo Alegría. (2009) Is it Time to Discard β-Blockers in Patients Undergoing Noncardiac Surgery?. American Journal Cardiovascular Drugs 9:Supplement 1, 23-26
CrossRef75
Don Poldermans, Jeroen J. Bax, Eric Boersma, Stefan de Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G. Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, José López-Sendón, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav F.M. Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen. (2009) Guía de práctica clínica para la valoración del riesgo cardiaco preoperatorio y el manejo cardiaco perioperatorio en la cirugía no cardiaca. Revista Española de Cardiología 62:12, 1467.e1-1467.e56
CrossRef76
Miklós D. Kertai, János Gál. (2009) Preoperative coronary revascularization for the reduction of perioperative ischemic complications in patients undergoing major vascular surgery. Interventional Medicine and Applied Science 1:1, 12-19
CrossRef77
, D. Poldermans, J. J. Bax, E. Boersma, S. De Hert, E. Eeckhout, G. Fowkes, B. Gorenek, M. G. Hennerici, B. Iung, M. Kelm, K. P. Kjeldsen, S. D. Kristensen, J. Lopez-Sendon, P. Pelosi, F. Philippe, L. Pierard, P. Ponikowski, J.-P. Schmid, O. F.M. Sellevold, R. Sicari, G. Van den Berghe, F. Vermassen, , S. E. Hoeks, I. Vanhorebeek, , A. Vahanian, A. Auricchio, J. J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, K. McGregor, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, P. Vardas, P. Widimsky, , R. De Caterina, S. Agewall, N. Al Attar, F. Andreotti, S. D. Anker, G. Baron-Esquivias, G. Berkenboom, L. Chapoutot, R. Cifkova, P. Faggiano, S. Gibbs, H. S. Hansen, L. Iserin, C. W. Israel, R. Kornowski, N. M. Eizagaechevarria, M. Pepi, M. Piepoli, H. J. Priebe, M. Scherer, J. Stepinska, D. Taggart, M. Tubaro. (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). European Heart Journal 30:22, 2769-2812
CrossRef78
Kirsten E. Fleischmann, Joshua A. Beckman, Christopher E. Buller, Hugh Calkins, Lee A. Fleisher, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, John F. Robb, R. James Valentine. (2009) 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade. Journal of the American College of Cardiology 54:22, 2102-2128
CrossRef79
Tenille E. Ragoonanan, W Scott Beattie, C David Mazer, Albert K.Y. Tsui, Howard Leong-Poi, David F. Wilson, Gordon Tait, Julie Yu, Elaine Liu, Melissa Noronha, Neil D. Dattani, Nicholas Mitsakakis, Gregory M. T. Hare. (2009) Metoprolol Reduces Cerebral Tissue Oxygen Tension after Acute Hemodilution in Rats. Anesthesiology 111:5, 988-1000
CrossRef80
Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh Calkins, Elliot L. Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, Barbara Riegel, John F. Robb. (2009) 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery. Journal of the American College of Cardiology 54:22, e13-e118
CrossRef81
Duminda N Wijeysundera, Jennifer S Bender, W Scott Beattie, Duminda N Wijeysundera. 2009. Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery. .
CrossRef82
Wilton A. van Klei, Gregory L. Bryson, Homer Yang, Alan J. Forster. (2009) Effect of β-blocker Prescription on the Incidence of Postoperative Myocardial Infarction after Hip and Knee Arthroplasty. Anesthesiology 111:4, 717-724
CrossRef83
E. Kothmann, A. M. Batterham, S. J. Owen, A. J. Turley, M. Cheesman, A. Parry, G. Danjoux. (2009) Effect of short-term exercise training on aerobic fitness in patients with abdominal aortic aneurysms: a pilot study. British Journal of Anaesthesia 103:4, 505-510
CrossRef84
Andrew B. Leibowitz, Steven B. Porter. (2009) Perioperative Β-Blockade in Patients Undergoing Noncardiac Surgery: A Review of the Major Randomized Clinical Trials. Journal of Cardiothoracic and Vascular Anesthesia 23:5, 684-693
CrossRef85
Mario Monaco, Paolo Stassano, Luigi Di Tommaso, Paolo Pepino, Arturo Giordano, Giovanni B. Pinna, Gabriele Iannelli, Giuseppe Ambrosio. (2009) Systematic Strategy of Prophylactic Coronary Angiography Improves Long-Term Outcome After Major Vascular Surgery in Medium- to High-Risk Patients. Journal of the American College of Cardiology 54:11, 989-996
CrossRef86
Matthew D. Neal, Joseph Cushieri, Matthew R. Rosengart, Louis H. Alarcon, Ernest E. Moore, Ronald V. Maier, Joseph P. Minei, Timothy R. Billiar, Andrew B. Peitzman, Jason L. Sperry. (2009) Preinjury Statin Use Is Associated With a Higher Risk of Multiple Organ Failure After Injury: A Propensity Score Adjusted Analysis. The Journal of Trauma: Injury, Infection, and Critical Care 67:3, 476-484
CrossRef87
James B. Froehlich, Lee A. Fleisher. (2009) Noncardiac Surgery in the Patient with Heart Disease. Medical Clinics of North America 93:5, 995-1016
CrossRef88
Freddie M. Williams, James D. Bergin. (2009) Cardiac Screening Before Noncardiac Surgery. Surgical Clinics of North America 89:4, 747-762
CrossRef89
T. Nowak, K.M. Balzer, H. Böhner. (2009) Die Bedeutung der perioperativen medikamentösen Therapie für das Ergebnis gefäßchirurgischer Operationen. Gefässchirurgie 14:4, 301-307
CrossRef90
Hasan H. Dosluoglu, Purandath Lall, Gregory S. Cherr, Linda M. Harris, Maciej L. Dryjski. (2009) Superior limb salvage with endovascular therapy in octogenarians with critical limb ischemia. Journal of Vascular Surgery 50:2, 305-316.e2
CrossRef91
Sébastien Gilbert, Blair A. Jobe. (2009) Surgical Therapy for Barrett's Esophagus with High-Grade Dysplasia and Early Esophageal Carcinoma. Surgical Oncology Clinics of North America 18:3, 523-531
CrossRef92
Avery Tung. (2009) Risk, Uncertainty, and Medical Decision-making: How Can We Make Better Decisions?. ASA Refresher Courses in Anesthesiology 37:1, 207-217
CrossRef93
T. Möllhoff, H.J. Kress. (2009) Perioperative Myokardschäden bei nichtkardiochirurgischen Patienten. Der Anaesthesist 58:7, 661-662
CrossRef94
Ronak G. Desai, Muhammad Muntazar, Michael E. Goldberg. (2009) Strategies for managing perioperative hypertension. Current Hypertension Reports 11:3, 173-177
CrossRef95
Willem-Jan Flu, Jan-Peter van Kuijk, Tamara Winkel, Sanne Hoeks, Jeroen Bax, Don Poldermans. (2009) Prevention of acute coronary events in noncardiac surgery: β-blocker therapy and coronary revascularization. Expert Review of Cardiovascular Therapy 7:5, 521-532
CrossRef96
S. Suttner, J. Boldt, A. Mengistu, K. Lang, J. Mayer. (2009) Influence of continuous perioperative beta-blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high-risk vascular surgery patients. British Journal of Anaesthesia 102:5, 597-607
CrossRef97
Maureen McNeely, Neil Roy Connelly. (2009) Questionable benefit of perioperative beta-blockade. Journal of Clinical Anesthesia 21:3, 232-233
CrossRef98
Thomas H. Marwick, Helen Branagan, Bala Venkatesh, Simon Stewart. (2009) Use of a nurse-led intervention to optimize beta-blockade for reducing cardiac events after major noncardiac surgery. American Heart Journal 157:4, 784-790
CrossRef99
Karl E. Hammermeister, Diane Fairclough, Caroline Bublitz Emsermann, Richard Hamman, Michael Ho, Stephanie Phibbs, Mary Plomondon, Robert Valuck, David West, John F. Steiner. (2009) Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure. Clinical Therapeutics 31:3, 632-643
CrossRef100
Vineet Chopra, Benjamin Plaisance, Erdal Cavusoglu, Scott A. Flanders, Kim A. Eagle. (2009) Perioperative Beta-blockers for Major Noncardiac Surgery: Primum Non Nocere. The American Journal of Medicine 122:3, 222-229
CrossRef101
Penelope M. A. Brasher, W. Scott Beattie. (2009) Adjusting clinical prediction rules: an academic exercise or the potential for real world clinical applications in perioperative medicine?. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 56:3, 190-193
CrossRef102
Seine Chiang, Kimberly A Gerten, Evelyn Granieri, Holly E Richter. (2009) Pharmacologic management of the older woman undergoing surgery. Women's Health 5:2, 205-219
CrossRef103
M. D. Stoneham, J. P. Thompson. (2009) Arterial pressure management and carotid endarterectomy. British Journal of Anaesthesia 102:4, 442-452
CrossRef104
Kristóf Rácz, Tamás Tiszai-Szűcs, János Gál, Miklós Kertai D.. (2009) Preoperatív revascularisatio nagy kockázatú, érsebészeti betegeknél. Orvosi Hetilap 150:8, 341-352
CrossRef105
Willem-Jan Flu, Sanne E. Hoeks, Jan-Peter Kuijk, Jeroen J. Bax, Don Poldermans. (2009) Treatment recommendations to prevent myocardial ischemia and infarction in patients undergoing vascular surgery. Current Treatment Options in Cardiovascular Medicine 11:1, 33-44
CrossRef106
Willem-Jan Flu, Tamara A Winkel, Jeroen J Bax, Don Poldermans. (2009) Bisoprolol in patients with chronic heart failure undergoing noncardiac surgery. Aging Health 5:1, 19-27
CrossRef107
James Rough, Ryan Engdahl, Kay Opperman, Smitha Yerrum, M. Alexandra Monroy, John M. Daly. (2009) β2 Adrenoreceptor blockade attenuates the hyperinflammatory response induced by traumatic injury. Surgery 145:2, 235-242
CrossRef108
Sachin Kheterpal, Michael O’Reilly, Michael J. Englesbe, Andrew L. Rosenberg, Amy M. Shanks, Lingling Zhang, Edward D. Rothman, Darrell A. Campbell, Kevin K. Tremper. (2009) Preoperative and Intraoperative Predictors of Cardiac Adverse Events after General, Vascular, and Urological Surgery. Anesthesiology 110:1, 58-66
CrossRef109
Murray F Brennan. (2008) Is nil per os still appropriate for patients undergoing upper gastrointestinal surgery?. Nature Clinical Practice Gastroenterology & Hepatology 5:12, 660-661
CrossRef110
Bobbie Jean Sweitzer. (2008) Preoperative screening, evaluation, and optimization of the patientʼs medical status before outpatient surgery. Current Opinion in Anaesthesiology 21:6, 711-718
CrossRef111
David L. Hepner, Darin J. Correll, Joshua A. Beckman, Robert J. Klickovich, Kenneth H. Park, Usha Govindarajulu, Angela M. Bader. (2008) Needs analysis for the development of a preoperative clinic protocol for perioperative beta-blocker therapy. Journal of Clinical Anesthesia 20:8, 580-588
CrossRef112
Rogier P.H.M. Müskens, Roger C.W. Wolfs, Jacqueline C.M. Witteman, Albert Hofman, Paulus T.V.M. de Jong, Bruno H.C. Stricker, Nomdo M. Jansonius. (2008) Topical β-Blockers and Mortality. Ophthalmology 115:11, 2037-2043
CrossRef113
Todd Neideen, Michelle Lam, Karen J. Brasel. (2008) Preinjury Beta Blockers are Associated With Increased Mortality in Geriatric Trauma Patients. The Journal of Trauma: Injury, Infection, and Critical Care 65:5, 1016-1020
CrossRef114
Matthias Bock, Christian J. Wiedermann. (2008) Perioperative Risikoreduktion – eine interdisziplinäre Herausforderung. Wiener Medizinische Wochenschrift 158:21-22, 590-594
CrossRef115
Stephen K. Sigworth. (2008) Preoperative evaluation of hospitalized patients. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 75:5, 442-448
CrossRef116
Laura Elizabeth Happe, Eileen Marie Farrelly, Richard H. Stanford, Matt William Sarnes. (2008) Cost and occurrence of thrombocytopenia in patients receiving venous thromboembolism prophylaxis following major orthopaedic surgeries. Journal of Thrombosis and Thrombolysis 26:2, 125-131
CrossRef117
Paul Cesanek, Nanette Schwann, Eric Wilson, Sallie Urffer, Crystal Maksimik, Susan Nabhan, Joe Ottinger, Jeff Astbury, Yufei Xiang, Martin E. Matsumura. (2008) The Effect of Beta-Blocker Dosing Strategy on Regulation of Perioperative Heart Rate and Clinical Outcomes in Patients Undergoing Vascular Surgery: A Randomized Comparison. Annals of Vascular Surgery 22:5, 643-648
CrossRef118
Paul Cesanek, Nanette Schwann, Eric Wilson, Sallie Urffer, Crystal Maksimik, Susan Nabhan, Joe Ottinger, Jeff Astbury, Yufei Xiang, Martin E. Matsumura. (2008) Influence de la stratégie de dosage des bêtabloquants sur la régulation de la fréquence cardiaque peropératoire et les résultats cliniques chez les opérés de chirurgie vasculaire : Étude randomisée. Annales de Chirurgie Vasculaire 22:5, 697-703
CrossRef119
Marie-Claude Parent, Stéphane Rinfret. (2008) The unresolved issues with risk stratification and management of patients with coronary artery disease undergoing major vascular surgery. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 55:8, 542-556
CrossRef120
M. Petzoldt, J. Kähler, A.E. Goetz, P. Friederich. (2008) Perioperative medikamentöse Kardioprotektion. Der Anaesthesist 57:7, 655-669
CrossRef121
Robina Matyal. (2008) Newly Appreciated Pathophysiology of Ischemic Heart Disease in Women Mandates Changes in Perioperative Management: A Core Review. Anesthesia & Analgesia 107:1, 37-50
CrossRef122
Frederick C. Basilico, Gerard Sweeney, Elena Losina, James Gaydos, Debra Skoniecki, Elizabeth A. Wright, Jeffrey N. Katz. (2008) Risk factors for cardiovascular complications following total joint replacement surgery. Arthritis & Rheumatism 58:7, 1915-1920
CrossRef123
B. M. Biccard, S. J. Howell. (2008) Calcium channel blockers, beta-blockers, and perioperative cardiovascular stability. British Journal of Anaesthesia 101:4, 439-441
CrossRef124
Edward Crosby. (2008) Innovation in medical practice: from new idea to standard of care. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 55:6, 328-336
CrossRef125
Robina Matyal, Feroze Mahmood, Peter Panzica, Frank Pomposelli, Kyung W. Park, Allen Hamden, Mark Schermerhorn, Philip Hess. (2008) Sex-Related Differences in Outcome After High-Risk Vascular Surgery After the Administration of β-Adrenergic–Blocking Drugs. Journal of Cardiothoracic and Vascular Anesthesia 22:3, 354-360
CrossRef126
Peter Kranke, Andreas Redel, Frank Schuster, Ralf Muellenbach, Leopold H Eberhart. (2008) Pharmacological interventions and concepts of fast-track perioperative medical care for enhanced recovery programs. Expert Opinion on Pharmacotherapy 9:9, 1541-1564
CrossRef127
Vesna Miodrag Karapandzic, Bosiljka D. Vujisic-Tesic, Predrag M. Pesko, Brankica M. Nenadic, Dragan D. Babic. (2008) The effect of metoprolol on perioperative outcome in coronary patients undergoing nonvascular abdominal surgery. Journal of Clinical Anesthesia 20:4, 284-289
CrossRef128
Ju-Mei Ng. (2008) Perioperative Anesthetic Management for Esophagectomy. Anesthesiology Clinics 26:2, 293-304
CrossRef129
Ashraf Fayad, Homer Yang, Terry Ruddy, Jim Watters, George Wells. (2008) Perioperative myocardial ischemia in isolated systolic hypertension (promise): A preliminary report. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 55:S1, 4718551-4718551
CrossRef130
Magnus A. Garrioch, A.C. Pichel. (2008) Reducing the risk of vascular surgery. Current Anaesthesia & Critical Care 19:3, 128-137
CrossRef131
(2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. The Lancet 371:9627, 1839-1847
CrossRef132
Don Poldermans, Sanne E. Hoeks, Harm H. Feringa. (2008) Pre-Operative Risk Assessment and Risk Reduction Before Surgery. Journal of the American College of Cardiology 51:20, 1913-1924
CrossRef133
Randall S. Friese, Robert Barber, Dara McBride, Jessica Bender, Larry M. Gentilello. (2008) Could Beta Blockade Improve Outcome After Injury by Modulating Inflammatory Profiles?. The Journal of Trauma: Injury, Infection, and Critical Care 64:4, 1061-1068
CrossRef134
Daniel R. Ouellette, Javier Diaz. (2008) Elevation of the Double Product During Flexible Bronchoscopy: Effects of Uncontrolled Hypertension and the Use of ??-Blockade. Journal of Bronchology 15:2, 73-77
CrossRef135
Debora L. Ryder. (2008) The Use of ??-Blockers to Decrease Adverse Perioperative Cardiac Events. Dimensions of Critical Care Nursing 27:2, 47-53
CrossRef136
Paul J. Grant, David H. Wesorick. (2008) Perioperative Medicine for the Hospitalized Patient. Medical Clinics of North America 92:2, 325-348
CrossRef137
Miklos D. Kertai. (2008) Preoperative Coronary Revascularization in High-Risk Patients Undergoing Vascular Surgery: A Core Review. Anesthesia & Analgesia 106:3, 751-758
CrossRef138
Luciano Babuin, Vlad C. Vasile, Jose A. Rio Perez, Jorge R. Alegria, High-Seng Chai, Bekele Afessa, Allan S. Jaffe. (2008) Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Critical Care Medicine 36:3, 759-765
CrossRef139
Shamsuddin Akhtar, Sheriff Assaad, Muzna Amin, Natalie F. Holt, Paul G. Barash, David G. Silverman. (2008) Preoperative β-blocker use: impact of national guidelines on clinical practice. Journal of Clinical Anesthesia 20:2, 122-128
CrossRef140
Martin J. London. (2008) Beta blockers and alpha2 agonists for cardioprotection. Best Practice & Research Clinical Anaesthesiology 22:1, 95-110
CrossRef141
Schneeweiss, Sebastian, Seeger, John D., Landon, Joan, Walker, Alexander M., . (2008) Aprotinin during Coronary-Artery Bypass Grafting and Risk of Death. New England Journal of Medicine 358:8, 771-783
Full Text142
Steven L. Cohn. (2008) Preoperative Cardiac Evaluation of Lung Resection Candidates. Thoracic Surgery Clinics 18:1, 45-59
CrossRef143
Suhal S. Mahid, Hiram C. Polk, John N. Lewis, Matthias Turina. (2008) Opportunities for Improved Performance in Surgical Specialty Practice. Annals of Surgery 247:2, 380-388
CrossRef144
Colleen Christmas, Roy C. Ziegelstein, Lee A. Fleisher. 2008. Perioperative Cardiovascular Evaluation and Treatment of Elderly Patients Undergoing Noncardiac Surgery. , 769-810.
CrossRef145
Geraldine Daumerie, Lee A Fleisher. (2008) Perioperative ??-blocker and statin therapy. Current Opinion in Anaesthesiology 21:1, 60-65
CrossRef146
Vin-Cent Wu, Wen-Je Ko, Hong-Wei Chang, Yung-Wei Chen, Yu-Feng Lin, Chih-Chung Shiao, Yung-Ming Chen, Yih-Sharng Chen, Pi-Ru Tsai, Fu-Chang Hu, Jann-Yuan Wang, Yen-Hung Lin, Kwan-Dun Wu, . (2008) Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy. Intensive Care Medicine 34:1, 101-108
CrossRef147
Monica Gilbert, Carole Staley, Sharryn Lydall-Smith, David J Castle. (2008) Use of Collaboration to Improve Outcomes in Chronic Disease. Disease Management & Health Outcomes 16:6, 381-390
CrossRef148
Bertram L. Kasiske, Ajay K. Israni. 2008. Cardiovascular Complications after Renal Transplantation. , 469-491.
CrossRef149
S.J. Howell, R.S. Vohra. (2007) Perioperative Management of Patients Undergoing Non-cardiac Vascular Surgery. European Journal of Vascular and Endovascular Surgery 34:6, 625-631
CrossRef150
Paul F White, Matthew Eng. (2007) Fast-track anesthetic techniques for ambulatory surgery. Current Opinion in Anaesthesiology 20:6, 545-557
CrossRef151
Sachin Kheterpal, Kevin K. Tremper, Michael J. Englesbe, Michael O’Reilly, Amy M. Shanks, Douglas M. Fetterman, Andrew L. Rosenberg, Richard D. Swartz. (2007) Predictors of Postoperative Acute Renal Failure after Noncardiac Surgery in Patients with Previously Normal Renal Function. Anesthesiology 107:6, 892-902
CrossRef152
Lee A Fleisher. (2007) Should my outpatient center have a β-blocker protocol?. Current Opinion in Anaesthesiology 20:6, 526-530
CrossRef153
Stefano Lucreziotti, Serena Conforti, Francesca Carletti, Giulia Santaguida, Stefano Meda, Federico Raveglia, Fabrizio Tundo, Tiziana Panigalli, Maria L. Biondi, Maurizio Mezzetti, Cesare Fiorentini. (2007) Elevaciones de la troponina I cardiaca tras la cirugía torácica. Incidencia y correlaciones con las características clínicas basales, la proteína C reactiva y los parámetros perioperatorios. Revista Española de Cardiología 60:11, 1159-1166
CrossRef154
Kristen L. Biggs, Wesley S. Moore. (2007) Current Trends in Managing Carotid Artery Disease. Surgical Clinics of North America 87:5, 995-1016
CrossRef155
Donat R. Spahn, Pierre-Guy Chassot, Michael Zaugg. (2007) Pragmatic Treatment versus Elaborative but Incomplete Testing. Anesthesiology 107:4, 526-529
CrossRef156
Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh Calkins, Elliott L. Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, Barbara Riegel, John F. Robb, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Elliott M. Antman, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, David P. Faxon, Valentin Fuster, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Bruce W. Lytle, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy. (2007) ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery. Journal of the American College of Cardiology 50:17, e159-e242
CrossRef157
Víctor G. Dávila-Román. (2007) Valoración del riesgo cardiaco de la cirugía no cardiaca. Revista Española de Cardiología 60:10, 1005-1009
CrossRef158
Vineet M. Arora, Marcia L. McGory, Constance H. Fung. (2007) Quality Indicators for Hospitalization and Surgery in Vulnerable Elders. Journal of the American Geriatrics Society 55, S347-S358
CrossRef159
Anika Backster, Alan Teo, Mini Swift, Hiram C. Polk, Alden H. Harken. (2007) Transforming the Surgical "Time-Out" Into a Comprehensive "Preparatory Pause". Journal of Cardiac Surgery 22:5, 410-416
CrossRef160
Ryoji Iida, Ken-ichi Iwasaki, Jitsu Kato, Shigeru Saeki, Setsuro Ogawa. (2007) Reflex Sympathetic Activity After Intravenous Administration of Midazolam in Anesthetized Cats. Anesthesia & Analgesia 105:3, 832-837
CrossRef161
J.E. Klein-Geltink, P.A. Rochon, S. Dyer, M. Laxer, G.M. Anderson. (2007) Readers should systematically assess methods used to identify, measure and analyze confounding in observational cohort studies. Journal of Clinical Epidemiology 60:8, 766.e1-766.e11
CrossRef162
Vin-Cent Wu, Wen-Je Ko, Hong-Wei Chang, Yih-Sharng Chen, Yung-Wei Chen, Young-Ming Chen, Fu-Chang Hu, Yen-Hung Lin, Pi-Ru Tsai, Kwan-Dun Wu. (2007) Early Renal Replacement Therapy in Patients with Postoperative Acute Liver Failure Associated with Acute Renal Failure: Effect on Postoperative Outcomes. Journal of the American College of Surgeons 205:2, 266-276
CrossRef163
Carolyn Berg, David H. Berger, Ayuk Makia, Caleb Whalen, Daniel Albo, Charles Bellows, Samir S. Awad. (2007) Perioperative β-blocker therapy and heart rate control during noncardiac surgery. The American Journal of Surgery 194:2, 189-191
CrossRef164
H.-H. Osterhues (federführend), F.M. Baer, M. Kelm, M. Irmer (BNK), K. Ivens, M. Leschke (ALKK), A. Meißner (DGAI), M. Pauschinger, B. Ritter (BNK), J. Röther (DGN). (2007) Kommentar zu den Leitlinien zur perioperativen kardiovaskulären Evaluation bei nichtkardialer Chirurgie der ACC/AHA. Der Kardiologe 1:1, 18-30
CrossRef165
Michael Zaugg, Lukas Bestmann, Johannes Wacker, Eliana Lucchinetti, Anita Boltres, Christian Schulz, Martin Hersberger, Gabriela K??lin, Lukas Furrer, Christoph Hofer, Stephan Blumenthal, Annabelle M??ller, Andreas Zollinger, Donat R. Spahn, Alain Borgeat. (2007) Adrenergic Receptor Genotype but Not Perioperative Bisoprolol Therapy May Determine Cardiovascular Outcome in At-risk Patients Undergoing Surgery with Spinal Block. Anesthesiology 107:1, 33-44
CrossRef166
Olaf Schouten, Lee A. Fleisher, Martin J. London, Harm H. H. Feringa, Jeroen J. Bax, Don Poldermans. (2007) Perioperative ??-Blockade: Still Not Enough for Adequate Cardioprotection!. Anesthesia & Analgesia 105:1, 279-280
CrossRef167
Thomas W. Barrett, Motomi Mori, David De Boer. (2007) Association of ambulatory use of statins and beta-blockers with long-term mortality after vascular surgery. Journal of Hospital Medicine 2:4, 241-252
CrossRef168
John E. Ellis, Avery Tung, Hubert Lee, Kristen Kasza. (2007) Predictors of Perioperative β-Blockade Use in Vascular Surgery: A Mail Survey of United States Anesthesiologists. Journal of Cardiothoracic and Vascular Anesthesia 21:3, 330-336
CrossRef169
I. A. Scott, R. S. Lodge, D. M. Russell. (2007) Evidence-based guide to perioperative medicine. Internal Medicine Journal 37:6, 389-401
CrossRef170
Paul F. White, Henrik Kehlet, Joseph M. Neal, Thomas Schricker, Daniel B. Carr, Franco Carli. (2007) The Role of the Anesthesiologist in Fast-Track Surgery: From Multimodal Analgesia to Perioperative Medical Care. Anesthesia & Analgesia 104:6, 1380-1396
CrossRef171
Steven L. Cohn, Andrew D. Auerbach. (2007) Preoperative cardiac risk stratification 2007: Evolving evidence, evolving strategies. Journal of Hospital Medicine 2:3, 174-180
CrossRef172
Donna L. Mercado, David Y. Ling, Gerald W. Smetana. (2007) Perioperative Cardiac Evaluation: Novel Interventions and Clinical Challenges. Southern Medical Journal 100:5, 486-492
CrossRef173
Melissa R. Kaufman, Roxelyn G. Baumgartner, Laura W. Anderson, Joseph A. Smith, Sam S. Chang, S. Duke Herrell, Michael S. Cookson. (2007) The evidence-based pathway for peri-operative management of open and robotically assisted laparoscopic radical prostatectomy. BJU International 99:5, 1103-1108
CrossRef174
Mario Abbud-Filho, Patricia L. Adams, Josefina Alber??, Carl Cardella, Jeremy Chapman, Pierre Cochat, Fernando Cosio, Gabriel Danovitch, Connie Davis, Robert S. Gaston, Atul Humar, Lawrence G. Hunsicker, Michelle A. Josephson, Bertram Kasiske, G??nter Kirste, Alan Leichtman, Stephen Munn, Gregorio T. Obrador, Annika Tibell, Jonas Wadstr??m, Martin Zeier, Francis L. Delmonico. (2007) A Report of the Lisbon Conference on the Care of the Kidney Transplant Recipient. Transplantation 83:Supplement, S1-S22
CrossRef175
Markus Lange, Norbert Roewer, Franz Kehl. (2007) Beta-blockers and anesthetic preconditioning: friend or foe?. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 54:4, 320-321
CrossRef176
Terry Altpeter, Kitty Luckhardt, John N. Lewis, Alden H. Harken, Hiram C. Polk. (2007) Expanded Surgical Time Out: A Key to Real-Time Data Collection and Quality Improvement. Journal of the American College of Surgeons 204:4, 527-532
CrossRef177
Sondra Vazirani, Neil M. Paige, Aksone Nouvong, David Aungst. (2007) Evaluating and Minimizing Cardiac Risk in Surgical Patients. Clinics in Podiatric Medicine and Surgery 24:2, 261-283
CrossRef178
M. Antonello, S. Lepidi, A. Kechagias, P. Frigatti, A. Tripepi, F. Biancari, G.P. Deriu, F. Grego. (2007) Glasgow Aneurysm Score Predicts the Outcome after Emergency Open Repair of Symptomatic, Unruptured Abdominal Aortic Aneurysms. European Journal of Vascular and Endovascular Surgery 33:3, 272-276
CrossRef179
Nils Butte, B.W. Böttiger, P. Teschendorf. (2007) Perioperative Kardioprotektion. Der Anaesthesist 56:3, 285-298
CrossRef180
Stephen H Pennefather. (2007) Anaesthesia for oesophagectomy. Current Opinion in Anaesthesiology 20:1, 15-20
CrossRef181
Peter G. Noordzij, Don Poldermans, Olaf Schouten, Frodo Schreiner, Harm H.H. Feringa, Martin Dunkelgrun, Miklos D. Kertai, Eric Boersma. (2007) Beta-blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac, nonvascular surgery. Coronary Artery Disease 18:1, 67-72
CrossRef182
Martin J. London. (2007) Con: Beta-Blockers Are Indicated for All Adults at Increased Risk Undergoing Noncardiac Surgery. Anesthesia & Analgesia 104:1, 11-14
CrossRef183
Lee A. Fleisher. (2007) Perioperative ??-Blockade: How Best to Translate Evidence into Practice. Anesthesia & Analgesia 104:1, 1-3
CrossRef184
S.E. Hoeks, W.J.M. Scholte op Reimer, H. van Urk, P.J.G. Jörning, E. Boersma, M.L. Simoons, J.J. Bax, D. Poldermans. (2007) Increase of 1-year Mortality After Perioperative Beta-blocker Withdrawal in Endovascular and Vascular Surgery Patients. European Journal of Vascular and Endovascular Surgery 33:1, 13-19
CrossRef185
Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh Calkins, Elliott L. Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, Barbara Riegel, John F. Robb. (2007) ACC/AHA 2006 Guideline Update on Perioperative Cardiovascular Evaluation for Noncardiac Surgery: Focused Update on Perioperative Beta-Blocker Therapy ??? A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesthesia & Analgesia 104:1, 15-26
CrossRef186
Olaf Schouten, Jeroen J. Bax, Martin Dunkelgrun, Harm H.H. Feringa, Don Poldermans. (2007) Pro: Beta-Blockers Are Indicated for Patients at Risk for Cardiac Complications Undergoing Noncardiac Surgery. Anesthesia & Analgesia 104:1, 8-10
CrossRef187
Franz Wiesbauer, Oliver Schlager, Hans Domanovits, Brigitte Wildner, Gerald Maurer, Marcus Muellner, Hermann Blessberger, Martin Schillinger. (2007) Perioperative ??-Blockers for Preventing Surgery-Related Mortality and Morbidity: A Systematic Review and Meta-Analysis. Anesthesia & Analgesia 104:1, 27-41
CrossRef188
Andrew F. Shorr, Louis M. Kwong, Matthew Sarnes, Laura Happe, Eileen Farrelly, Nikita Mody-Patel. (2007) Venous thromboembolism after orthopedic surgery: Implications of the choice for prophylaxis. Thrombosis Research 121:1, 17-24
CrossRef189
G.L. Moneta. (2007) Perioperative Beta-Blocker Therapy and Mortality after Major Noncardiac Surgery. Yearbook of Vascular Surgery 2007, 82-83
CrossRef190
Robert Feneck. (2007) Drugs for the Perioperative Control of Hypertension. Drugs 67:14, 2023-2044
CrossRef191
Bryan A. Cotton, Kimberly B. Snodgrass, Sloan B. Fleming, Robert O. Carpenter, Clinton D. Kemp, Patrick G. Arbogast, John A. Morris. (2007) Beta-Blocker Exposure is Associated With Improved Survival After Severe Traumatic Brain Injury. The Journal of Trauma: Injury, Infection, and Critical Care 62:1, 26-35
CrossRef192
Chance Irwin, Kenneth J. Woodside, Glenn C. Hunter. (2007) The Role of Carotid Surgery in Prevention of Stroke in Frail Elderly Patients. Journal of the American College of Surgeons 204:1, 140-147
CrossRef193
Atif Qasim, David Horowitz. 2007. Preoperative Cardiovascular Risk Assessment. , 90-123.
CrossRef194
Mohammed M. Minhaj, John E Ellis. (2007) Myocardial Ischemia and Infarction. ASA Refresher Courses in Anesthesiology 35:1, 127-144
CrossRef195
Colleen Christmas, Martin A. Makary, John R. Burton. (2006) Medical Considerations in Older Surgical Patients. Journal of the American College of Surgeons 203:5, 746-751
CrossRef196
Nader N. Boushra, Muhammad Muntazar. (2006) Review article: The role of statins in reducing perioperative cardiac risk: physiologic and clinical perspectives. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 53:11, 1126-1147
CrossRef197
R. Strametz, B. Zwissler. (2006) Nutzen der perioperativen β-Blockade. Der Anaesthesist 55:11, 1197-1204
CrossRef198
B. M. Biccard, J. W. Sear, P. Foëx. (2006) Acute peri-operative beta blockade in intermediate-risk patients. Anaesthesia 61:10, 924-931
CrossRef199
Kim A. Eagle, Wei C. Lau. (2006) Any Need for Preoperative Cardiac Testing in Intermediate-Risk Patients With Tight Beta-Adrenergic Blockade?
Editorials published in the Journal of American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.. Journal of the American College of Cardiology 48:5, 970-972
CrossRef200
Herbert B. Ward, Rosemary F. Kelly, Lizy Thottapurathu, Thomas E. Moritz, Greg C. Larsen, Gordon Pierpont, Steve Santilli, Steven Goldman, William C. Krupski, Fred Littooy, Domenic J. Reda, Edward O. McFalls. (2006) Coronary Artery Bypass Grafting is Superior to Percutaneous Coronary Intervention in Prevention of Perioperative Myocardial Infarctions During Subsequent Vascular Surgery. The Annals of Thoracic Surgery 82:3, 795-801
CrossRef201
Ramesh Venkataraman. (2006) Vascular surgery critical care: Perioperative cardiac optimization to improve survival. Critical Care Medicine 34:Suppl, S200-S207
CrossRef202
Leanne Groban, John Butterworth. (2006) Perioperative Management of Chronic Heart Failure. Anesthesia & Analgesia 103:3, 557-575
CrossRef203
T. Meinertz, T. Eschenhagen. (2006) β-Rezeptorenblocker bei kardiovaskulären Erkrankungen. Clinical Research in Cardiology Supplements 1:1, 43-54
CrossRef204
D KURZENCWYG, K FILION, L PILOTE, P NAULT, R PLATT, E RAHME, O STEINMETZ, M EISENBERG. (2006) Cardiac Medical Therapy among Patients Undergoing Abdominal Aortic Aneurysm Repair. Annals of Vascular Surgery 20:5, 569-576
CrossRef205
Don Poldermans, Jeroen J. Bax, Olaf Schouten, Aleksandar N. Neskovic, Bernard Paelinck, Guido Rocci, Laura van Dortmont, Anai E.S. Durazzo, Louis L.M. van de Ven, Marc R.H.M. van Sambeek, Miklos D. Kertai, Eric Boersma. (2006) Should Major Vascular Surgery Be Delayed Because of Preoperative Cardiac Testing in Intermediate-Risk Patients Receiving Beta-Blocker Therapy With Tight Heart Rate Control?. Journal of the American College of Cardiology 48:5, 964-969
CrossRef206
Giuseppe Papia, David Klein, Thomas F Lindsay. (2006) Intensive care of the patient following open abdominal aortic surgery. Current Opinion in Critical Care 12:4, 340-345
CrossRef207
M. D. Kertai, L. Bogar, J. Gal, D. Poldermans. (2006) Pre-operative coronary revascularization: an optimal therapy for high-risk vascular surgery patients?. Acta Anaesthesiologica Scandinavica 50:7, 816-827
CrossRef208
Dale W. Bratzler, David R. Hunt. (2006) Healthcare Epidemiology: The Surgical Infection Prevention and Surgical Care Improvement Projects: National Initiatives to Improve Outcomes for Patients Having Surgery. Clinical Infectious Diseases 43:3, 322-330
CrossRef209
Mina Nishimori, Jane C Ballantyne, James HS Low, Mina Nishimori. 2006. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery. .
CrossRef210
Paul J. Lama. (2006) Topical β-Adrenergic Blockers and Glaucoma: A Heart-Stopping Association?. Ophthalmology 113:7, 1067-1068
CrossRef211
Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh Calkins, Elliott Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, Barbara Riegel, John F. Robb, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Elliott M. Antman, David P. Faxon, Valentin Fuster, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Bruce W. Lytle, Rick Nishimura, Richard L. Page, Barbara Riegel. (2006) ACC/AHA 2006 Guideline Update on Perioperative Cardiovascular Evaluation for Noncardiac Surgery: Focused Update on Perioperative Beta-Blocker Therapy. Journal of the American College of Cardiology 47:11, 2343-2355
CrossRef212
Wilton C. Levine, Vipin Mehta, Giora Landesberg. (2006) Anesthesia for the elderly: selected topics. Current Opinion in Anaesthesiology 19:3, 320-324
CrossRef213
Satoshi Hanada, Hiromasa Kawakami, Takahisa Goto, Shigeho Morita. (2006) Hypertension and anesthesia. Current Opinion in Anaesthesiology 19:3, 315-319
CrossRef214
David R. Bevan. (2006) The future of academic anesthesia departments in Canada. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 53:6, 533-539
CrossRef215
Debra Quinn Kolodner, Huong Do, Mary Cooper, Eliot Lazar, Mark Callahan. (2006) Lack of Adherence with Preoperative B-blocker Recommendations in a Multicenter Study. Journal of General Internal Medicine 21:6, 596-601
CrossRef216
Jørn Wetterslev, Anne Benedicte Juul. (2006) Benefits and harms of perioperative beta-blockade. Best Practice & Research Clinical Anaesthesiology 20:2, 285-302
CrossRef217
Vivek K. Moitra, Steffen E. Meiler. (2006) The diabetic surgical patient. Current Opinion in Anaesthesiology 19:3, 339-345
CrossRef218
David Goldhill, Carl Waldmann. (2006) Excellent anaesthesia needs patient preparation and postoperative support to influence outcome. Current Opinion in Anaesthesiology 19:2, 192-197
CrossRef219
H. Pilmore. (2006) Cardiac Assessment for Renal Transplantation. American Journal of Transplantation 6:4, 659-665
CrossRef220
Albert T. Cheung. (2006) Exploring an Optimum Intra/Postoperative Management Strategy for Acute Hypertension in the Cardiac Surgery Patient. Journal of Cardiac Surgery 21:s1, S8-S14
CrossRef221
William C. Mackey, Lee A. Fleisher, Seema Haider, Saraih Sheikh, Joseph C. Cappelleri, Won Chan Lee, Qin Wang, Jennifer M. Stephens. (2006) Perioperative myocardial ischemic injury in high-risk vascular surgery patients: Incidence and clinical significance in a prospective clinical trial. Journal of Vascular Surgery 43:3, 533-538
CrossRef222
Daniel G. Hackam. (2006) Perioperative β-blocker therapy in vascular surgery: Clinical update. Journal of Vascular Surgery 43:3, 632-634
CrossRef223
H. C. Polk. (2006) Renewal of Surgical Quality and Safety Initiatives: A Multispecialty Challenge. Mayo Clinic Proceedings 81:3, 345-352
CrossRef224
B. M. Biccard, J. W. Sear, P. Foex. (2006) The pharmacoeconomics of peri-operative beta-blocker therapy. Anaesthesia 61:1, 4-8
CrossRef225
Rosemary F. Kelly, Edward O. McFalls. (2006) Preoperative evaluation and treatment of stable cad in patients scheduled for major elective vascular surgery. Current Treatment Options in Cardiovascular Medicine 8:1, 59-66
CrossRef226
Raymond C. Roy. (2006) What Is New in Geriatric Anesthesia?. ASA Refresher Courses in Anesthesiology 34:1, 139-150
CrossRef227
W Scott Beattie, Esam Abdelnaem, Duminda N. Wijeysundera, D Norman Buckley. (2006) A Meta-Analytic Comparison of Preoperative Stress Echocardiography and Nuclear Scintigraphy Imaging. Anesthesia & Analgesia 102:1, 8-16
CrossRef228
(2005) Perioperative Beta-Blocker Therapy and Mortality. New England Journal of Medicine 353:23, 2513-2515
Full Text229
Paul M. Maggio, Paul A. Taheri. (2005) Perioperative Issues: Myocardial Ischemia and Protection — Beta-Blockade. Surgical Clinics of North America 85:6, 1091-1102
CrossRef230
Poldermans, Don, Boersma, Eric, . (2005) Beta-Blocker Therapy in Noncardiac Surgery. New England Journal of Medicine 353:4, 412-414
Full Text
- Letters
